Columbus

Vi havde fornøjelse af at gå igennem Voldgiftsretten med Pharma Equity Group, sammen med bestyrelsesformand Christian Vinding, herudover er der netop nu spændene muligheder indenfor den danske IT-servicesektor.

Dagens aktienyheder 12/05-2026: Pharma Equity Group, Columbus, GomSpace og Ascelia Pharma

Following Columbus's Q1 2026 Interim Report published on 7 May, we have updated our investment case. Our updated investment case covers the key investment reasons and risks as well as valuation perspectives against a peer group of Nordic IT Service companies.

Columbus expects to release its Q1 2026 interim report on 7 May 2026. The same day at 13:00 CET, Columbus' CEO & President Søren Krogh Knudsen and CFO Brian Iversen will present the results and answer questions from the audience during a live online event.

This morning, Columbus released its Q1 2026 Interim Report. Performance for the quarter was below expectations, with revenue of DKK 418m corresponding to a 4% decline, and EBITDA of DKK 26m translating into a margin of 6.3% (Q1 2025: 10.7%). The earnings development primarily reflects a slow start to the year, particularly in January, with weaker-than-expected contribution margins across the Business Lines.

Mød ledelsen i INVISIO, Skjern Bank, GomSpace og Columbus, og stil spørgsmål til dagens investorpræsentationer